Key result
Dexmedetomidine significantly reduced mean arterial pressure at 1 minute after intubation compared to lidocaine and fentanyl (91.73 mmHg vs 104.07 mmHg and 102.9 mmHg, p=0.001) in cardiac surgery patients.
Why the study?
Laryngoscopy and intubation produce a sympathoadrenal response posing risks in cardiac patients due to arrhythmias and myocardial ischemia, increasing morbidity and mortality.
Does dexmedetomidine reduce the hemodynamic response to laryngoscopy and intubation compared to lidocaine and fentanyl in cardiac surgery patients?
RCT (n=90)
Double-blind
Sealed envelope method
No
Does dexmedetomidine reduce the hemodynamic response to laryngoscopy and intubation compared to lidocaine and fentanyl in cardiac surgery patients?
Absolute Event Rate: 91.73% vs 102.9%
p-value: p=0.001
Dexmedetomidine is more effective than fentanyl and lidocaine in blunting the hemodynamic response to intubation in cardiac surgery patients, though it carries a risk of significant hypotension.
May warrant caution with dexmedetomidine due to hypotension risk; leaves open optimal agent selection in cardiac patients.
Objective: Laryngoscopy and intubation produce sympathoadrenal response posing risk especially in cardiac patients due to arrhythmias, myocardial ischemia increasing morbidity and mortality. Our aim is to compare lidocaine, fentanyl and dexmedetomidine in attenuation of this response in cardiac surgery patients. Material and Methods: Ninety patients were allocated into 3 groups of 30 participants each. Group A obtained 1µg/kg Dexmedetomidine for 10 minutes before laryngoscopy. Group B 1.5mg/kg of Lidocaine and Group C 2µg/kg Fentanyl 90 seconds before intubation. Hemodynamic parameters like Heart rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Pressure (MAP) and Rate Pressure Product (RPP) were noted before intubation and 1,3,5,10 and 15 minutes after intubation. Statistical analysis was done using Epi info version 7.2.1.0 statistical software (Chi square test, ANOVA test). Results: Dexmedetomidine had significant reduction in SBP at 1st (p-value=0.003), 5th, 10th and 15th (p-value<0.001) minute and in DBP at 3rd, 5th, 10th and 15th (p-value< 0.001). MAP was significantly reduced with dexmedetomidine at 1st, 3rd, 5th, 10th and 15th minute (p-value</ = 0.001) and RPP at 1st (p-value=0.040), 3rd (p-value=0.001), 5th (p-value=0.001), 10th (p-value<0.001) and 15th(p-value=0.002) minute. Dexmedetomidine had higher fall in HR at 1st, 3rd, 5th, 10th mins which was not statistically significant(p-value>0.05). Conclusion: Dexmedetomidine 1µg/kg given as 10 min infusion before laryngoscopy was more effective than fentanyl and lidocaine in blunting hemodynamic response to laryngoscopy and intubation in cardiac surgery patients. However due to significant hypotension associated with dexmedetomidine, it has to be used with caution in these patients.
No takes yet. Share an insight, caveat, or question.
Kateel et al. (2023) conducted an RCT in Elective cardiac surgery (n=90). Dexmedetomidine vs. Lidocaine (1.5mg/kg) and Fentanyl (2µg/kg) was evaluated on Mean Arterial Pressure at 1 minute after intubation (p=0.001). Dexmedetomidine significantly reduced mean arterial pressure at 1 minute after intubation compared to lidocaine and fentanyl (91.73 mmHg vs 104.07 mmHg and 102.9 mmHg, p=0.001) in cardiac surgery patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: